Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.33 |
| ▸ | UBE2M | P61081 | 3/20 | 0.33 |
| ▸ | DCUN1D1 | Q96GG9 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.31 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29700417 | 0.90 | NPC1 (0.43) | FASNLIPGLMNAALDH1A1TP53 | |
| SCHEMBL26185573 | 0.90 | NPC1 (0.43) | FASNLIPGLMNAALDH1A1TP53 | |
| SCHEMBL26567770 | 0.80 | DYRK1A (0.36) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL26567777 | 0.80 | DYRK1A (0.35) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL24478917 | 0.79 | NPC1 (0.48) | FASNLIPGLMNATP53MAPT | |
| SCHEMBL26567808 | 0.74 | DYRK1A (0.38) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL26567751 | 0.73 | DYRK1A (0.38) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL26567794 | 0.73 | EPHX2 (0.38) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL26567817 | 0.73 | UBE2M (0.34) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 | |
| SCHEMBL26567756 | 0.73 | DYRK1A (0.36) | DYRK1AUBE2MDCUN1D1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331715-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331715-A1 | SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HAVCR2, NR1I3, NR1H4 | FASN 2941/4885DYRK1A 4673/4885LIPG 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.